Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average (2018 - 2025)

Eton Pharmaceuticals' Assets Average history spans 7 years, with the latest figure at $98.3 million for Q4 2025.

  • On a quarterly basis, Assets Average rose 75.61% to $98.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $98.3 million, a 75.61% increase, with the full-year FY2025 number at $84.1 million, up 55.97% from a year prior.
  • Assets Average hit $98.3 million in Q4 2025 for Eton Pharmaceuticals, down from $103.1 million in the prior quarter.
  • Over the last five years, Assets Average for ETON hit a ceiling of $103.1 million in Q3 2025 and a floor of $22.3 million in Q3 2022.
  • Historically, Assets Average has averaged $42.5 million across 5 years, with a median of $30.9 million in 2021.
  • Biggest five-year swings in Assets Average: decreased 24.31% in 2022 and later surged 204.72% in 2025.
  • Tracing ETON's Assets Average over 5 years: stood at $27.0 million in 2021, then dropped by 13.91% to $23.3 million in 2022, then soared by 35.91% to $31.6 million in 2023, then surged by 76.97% to $56.0 million in 2024, then surged by 75.61% to $98.3 million in 2025.
  • Business Quant data shows Assets Average for ETON at $98.3 million in Q4 2025, $103.1 million in Q3 2025, and $92.9 million in Q2 2025.